nodes	percent_of_prediction	percent_of_DWPC	metapath
Finasteride—Medrysone—Prednisolone—chronic obstructive pulmonary disease	0.241	0.422	CrCrCtD
Finasteride—Progesterone—Prednisolone—chronic obstructive pulmonary disease	0.177	0.309	CrCrCtD
Finasteride—Testosterone—Prednisolone—chronic obstructive pulmonary disease	0.154	0.268	CrCrCtD
Finasteride—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0523	0.282	CbGbCtD
Finasteride—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0353	0.19	CbGbCtD
Finasteride—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0337	0.182	CbGbCtD
Finasteride—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.03	0.162	CbGbCtD
Finasteride—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0176	0.0949	CbGbCtD
Finasteride—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0166	0.0897	CbGbCtD
Finasteride—SRD5A2—Metabolism of steroid hormones and vitamin D—GC—chronic obstructive pulmonary disease	0.00982	0.127	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of steroid hormones and vitamin D—GC—chronic obstructive pulmonary disease	0.00982	0.127	CbGpPWpGaD
Finasteride—Musculoskeletal disorder—Salbutamol—chronic obstructive pulmonary disease	0.0061	0.0372	CcSEcCtD
Finasteride—Trauma—Formoterol—chronic obstructive pulmonary disease	0.00484	0.0295	CcSEcCtD
Finasteride—Trauma—Arformoterol—chronic obstructive pulmonary disease	0.00484	0.0295	CcSEcCtD
Finasteride—Trauma—Montelukast—chronic obstructive pulmonary disease	0.00474	0.0289	CcSEcCtD
Finasteride—Gynaecomastia—Roflumilast—chronic obstructive pulmonary disease	0.00407	0.0248	CcSEcCtD
Finasteride—Influenza—Roflumilast—chronic obstructive pulmonary disease	0.00285	0.0174	CcSEcCtD
Finasteride—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00266	0.0343	CbGpPWpGaD
Finasteride—Trauma—Prednisolone—chronic obstructive pulmonary disease	0.00262	0.016	CcSEcCtD
Finasteride—AKR1D1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00252	0.0325	CbGpPWpGaD
Finasteride—Sinusitis—Roflumilast—chronic obstructive pulmonary disease	0.00238	0.0145	CcSEcCtD
Finasteride—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00235	0.0303	CbGpPWpGaD
Finasteride—Rhinitis—Roflumilast—chronic obstructive pulmonary disease	0.00229	0.0139	CcSEcCtD
Finasteride—Neoplasm—Formoterol—chronic obstructive pulmonary disease	0.00208	0.0127	CcSEcCtD
Finasteride—Neoplasm—Arformoterol—chronic obstructive pulmonary disease	0.00208	0.0127	CcSEcCtD
Finasteride—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00206	0.0126	CcSEcCtD
Finasteride—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.002	0.0122	CcSEcCtD
Finasteride—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00192	0.0248	CbGpPWpGaD
Finasteride—Trauma—Prednisone—chronic obstructive pulmonary disease	0.00191	0.0116	CcSEcCtD
Finasteride—AKR1D1—Bile acid and bile salt metabolism—ALB—chronic obstructive pulmonary disease	0.00183	0.0236	CbGpPWpGaD
Finasteride—Injury—Formoterol—chronic obstructive pulmonary disease	0.00182	0.0111	CcSEcCtD
Finasteride—Injury—Arformoterol—chronic obstructive pulmonary disease	0.00182	0.0111	CcSEcCtD
Finasteride—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00181	0.0111	CcSEcCtD
Finasteride—Injury—Montelukast—chronic obstructive pulmonary disease	0.00178	0.0109	CcSEcCtD
Finasteride—Injury—Salbutamol—chronic obstructive pulmonary disease	0.00172	0.0105	CcSEcCtD
Finasteride—Infection—Roflumilast—chronic obstructive pulmonary disease	0.00161	0.00982	CcSEcCtD
Finasteride—Sinusitis—Tiotropium—chronic obstructive pulmonary disease	0.0015	0.00914	CcSEcCtD
Finasteride—Influenza—Formoterol—chronic obstructive pulmonary disease	0.00145	0.00882	CcSEcCtD
Finasteride—Influenza—Arformoterol—chronic obstructive pulmonary disease	0.00145	0.00882	CcSEcCtD
Finasteride—Rhinitis—Tiotropium—chronic obstructive pulmonary disease	0.00144	0.00877	CcSEcCtD
Finasteride—Pharyngitis—Tiotropium—chronic obstructive pulmonary disease	0.00142	0.00868	CcSEcCtD
Finasteride—Influenza—Montelukast—chronic obstructive pulmonary disease	0.00142	0.00864	CcSEcCtD
Finasteride—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.00141	0.00862	CcSEcCtD
Finasteride—Bronchitis—Formoterol—chronic obstructive pulmonary disease	0.00139	0.00848	CcSEcCtD
Finasteride—Bronchitis—Arformoterol—chronic obstructive pulmonary disease	0.00139	0.00848	CcSEcCtD
Finasteride—Influenza—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00833	CcSEcCtD
Finasteride—Bronchitis—Montelukast—chronic obstructive pulmonary disease	0.00136	0.00831	CcSEcCtD
Finasteride—Bronchitis—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.00801	CcSEcCtD
Finasteride—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.0013	0.0079	CcSEcCtD
Finasteride—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00129	0.00785	CcSEcCtD
Finasteride—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.00126	0.00766	CcSEcCtD
Finasteride—CYP3A7—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00125	0.0162	CbGpPWpGaD
Finasteride—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.00738	CcSEcCtD
Finasteride—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.00121	0.00738	CcSEcCtD
Finasteride—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00119	0.00728	CcSEcCtD
Finasteride—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00723	CcSEcCtD
Finasteride—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00116	0.00709	CcSEcCtD
Finasteride—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00708	CcSEcCtD
Finasteride—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00708	CcSEcCtD
Finasteride—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00701	CcSEcCtD
Finasteride—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00701	CcSEcCtD
Finasteride—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00697	CcSEcCtD
Finasteride—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00696	CcSEcCtD
Finasteride—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00695	CcSEcCtD
Finasteride—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00695	CcSEcCtD
Finasteride—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00693	CcSEcCtD
Finasteride—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.00113	0.00686	CcSEcCtD
Finasteride—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00668	CcSEcCtD
Finasteride—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00661	CcSEcCtD
Finasteride—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00107	0.00655	CcSEcCtD
Finasteride—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00107	0.00653	CcSEcCtD
Finasteride—AKR1D1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00105	0.0135	CbGpPWpGaD
Finasteride—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00638	CcSEcCtD
Finasteride—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00638	CcSEcCtD
Finasteride—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00624	CcSEcCtD
Finasteride—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.00623	CcSEcCtD
Finasteride—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.00622	CcSEcCtD
Finasteride—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.00619	CcSEcCtD
Finasteride—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00618	CcSEcCtD
Finasteride—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00618	CcSEcCtD
Finasteride—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00101	0.00617	CcSEcCtD
Finasteride—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00101	0.00616	CcSEcCtD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00101	0.013	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00101	0.013	CbGpPWpGaD
Finasteride—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000994	0.00606	CcSEcCtD
Finasteride—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000988	0.00602	CcSEcCtD
Finasteride—Injury—Prednisolone—chronic obstructive pulmonary disease	0.000986	0.00601	CcSEcCtD
Finasteride—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000977	0.0126	CbGpPWpGaD
Finasteride—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000958	0.00584	CcSEcCtD
Finasteride—CYP3A5—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000945	0.0122	CbGpPWpGaD
Finasteride—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000921	0.00561	CcSEcCtD
Finasteride—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000921	0.00561	CcSEcCtD
Finasteride—CYP3A7—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000912	0.0118	CbGpPWpGaD
Finasteride—CYP3A5—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000907	0.0117	CbGpPWpGaD
Finasteride—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000902	0.0055	CcSEcCtD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000897	0.0116	CbGpPWpGaD
Finasteride—AKR1D1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000872	0.0113	CbGpPWpGaD
Finasteride—CYP3A5—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000872	0.0113	CbGpPWpGaD
Finasteride—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00087	0.0053	CcSEcCtD
Finasteride—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000859	0.00523	CcSEcCtD
Finasteride—Infection—Formoterol—chronic obstructive pulmonary disease	0.000817	0.00498	CcSEcCtD
Finasteride—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000817	0.00498	CcSEcCtD
Finasteride—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00081	0.00494	CcSEcCtD
Finasteride—AKR1D1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000802	0.0103	CbGpPWpGaD
Finasteride—Infection—Montelukast—chronic obstructive pulmonary disease	0.000801	0.00488	CcSEcCtD
Finasteride—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000796	0.00485	CcSEcCtD
Finasteride—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000772	0.0047	CcSEcCtD
Finasteride—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000769	0.00469	CcSEcCtD
Finasteride—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000769	0.00469	CcSEcCtD
Finasteride—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000765	0.00466	CcSEcCtD
Finasteride—AKR1D1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.00076	0.00981	CbGpPWpGaD
Finasteride—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000751	0.00458	CcSEcCtD
Finasteride—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000749	0.00966	CbGpPWpGaD
Finasteride—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000733	0.00447	CcSEcCtD
Finasteride—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000733	0.00447	CcSEcCtD
Finasteride—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000731	0.00446	CcSEcCtD
Finasteride—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000731	0.00446	CcSEcCtD
Finasteride—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000726	0.00442	CcSEcCtD
Finasteride—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000721	0.0044	CcSEcCtD
Finasteride—Injury—Prednisone—chronic obstructive pulmonary disease	0.000717	0.00437	CcSEcCtD
Finasteride—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000716	0.00437	CcSEcCtD
Finasteride—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000715	0.00436	CcSEcCtD
Finasteride—Pain—Formoterol—chronic obstructive pulmonary disease	0.000704	0.00429	CcSEcCtD
Finasteride—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000704	0.00429	CcSEcCtD
Finasteride—SRD5A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000696	0.00897	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000696	0.00897	CbGpPWpGaD
Finasteride—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000693	0.00422	CcSEcCtD
Finasteride—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000691	0.00421	CcSEcCtD
Finasteride—Pain—Montelukast—chronic obstructive pulmonary disease	0.000689	0.0042	CcSEcCtD
Finasteride—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000682	0.00415	CcSEcCtD
Finasteride—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000681	0.00415	CcSEcCtD
Finasteride—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000677	0.00413	CcSEcCtD
Finasteride—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000674	0.00411	CcSEcCtD
Finasteride—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000664	0.00405	CcSEcCtD
Finasteride—CYP3A5—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000659	0.0085	CbGpPWpGaD
Finasteride—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000654	0.00398	CcSEcCtD
Finasteride—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000654	0.00398	CcSEcCtD
Finasteride—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000643	0.00392	CcSEcCtD
Finasteride—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000642	0.00391	CcSEcCtD
Finasteride—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00064	0.0039	CcSEcCtD
Finasteride—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000639	0.00389	CcSEcCtD
Finasteride—CYP3A5—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000634	0.00818	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—APIP—chronic obstructive pulmonary disease	0.00062	0.008	CbGpPWpGaD
Finasteride—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000617	0.00376	CcSEcCtD
Finasteride—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000606	0.00369	CcSEcCtD
Finasteride—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000606	0.00369	CcSEcCtD
Finasteride—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000594	0.00362	CcSEcCtD
Finasteride—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00059	0.0036	CcSEcCtD
Finasteride—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00059	0.0036	CcSEcCtD
Finasteride—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000582	0.00355	CcSEcCtD
Finasteride—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000582	0.00355	CcSEcCtD
Finasteride—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00058	0.00749	CbGpPWpGaD
Finasteride—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000578	0.00352	CcSEcCtD
Finasteride—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000572	0.00349	CcSEcCtD
Finasteride—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00057	0.00348	CcSEcCtD
Finasteride—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000557	0.0034	CcSEcCtD
Finasteride—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00055	0.00335	CcSEcCtD
Finasteride—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000544	0.00332	CcSEcCtD
Finasteride—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000544	0.00332	CcSEcCtD
Finasteride—CYP3A7—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000533	0.00688	CbGpPWpGaD
Finasteride—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000533	0.00325	CcSEcCtD
Finasteride—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000524	0.0032	CcSEcCtD
Finasteride—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000521	0.00672	CbGpPWpGaD
Finasteride—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000519	0.00316	CcSEcCtD
Finasteride—Rash—Formoterol—chronic obstructive pulmonary disease	0.000519	0.00316	CcSEcCtD
Finasteride—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000518	0.00316	CcSEcCtD
Finasteride—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000518	0.00316	CcSEcCtD
Finasteride—Headache—Formoterol—chronic obstructive pulmonary disease	0.000515	0.00314	CcSEcCtD
Finasteride—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000515	0.00314	CcSEcCtD
Finasteride—CYP3A7—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000514	0.00664	CbGpPWpGaD
Finasteride—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000514	0.00313	CcSEcCtD
Finasteride—Rash—Montelukast—chronic obstructive pulmonary disease	0.000508	0.0031	CcSEcCtD
Finasteride—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000508	0.00309	CcSEcCtD
Finasteride—Headache—Montelukast—chronic obstructive pulmonary disease	0.000505	0.00308	CcSEcCtD
Finasteride—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000504	0.0065	CbGpPWpGaD
Finasteride—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000499	0.00304	CcSEcCtD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000496	0.0064	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000496	0.0064	CbGpPWpGaD
Finasteride—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00049	0.00299	CcSEcCtD
Finasteride—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000489	0.00298	CcSEcCtD
Finasteride—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000487	0.00297	CcSEcCtD
Finasteride—SRD5A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000461	0.00594	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000461	0.00594	CbGpPWpGaD
Finasteride—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000459	0.00592	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000457	0.0059	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000457	0.0059	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GC—chronic obstructive pulmonary disease	0.000448	0.00578	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GC—chronic obstructive pulmonary disease	0.000448	0.00578	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000442	0.0057	CbGpPWpGaD
Finasteride—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000439	0.00567	CbGpPWpGaD
Finasteride—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000422	0.00545	CbGpPWpGaD
Finasteride—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000422	0.00544	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000417	0.00538	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000417	0.00538	CbGpPWpGaD
Finasteride—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000412	0.00251	CcSEcCtD
Finasteride—AKR1D1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000411	0.0053	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000407	0.00525	CbGpPWpGaD
Finasteride—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000406	0.00523	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GC—chronic obstructive pulmonary disease	0.000399	0.00515	CbGpPWpGaD
Finasteride—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000399	0.00243	CcSEcCtD
Finasteride—CYP3A5—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000385	0.00497	CbGpPWpGaD
Finasteride—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000381	0.00232	CcSEcCtD
Finasteride—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000379	0.00489	CbGpPWpGaD
Finasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000377	0.00486	CbGpPWpGaD
Finasteride—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000374	0.00482	CbGpPWpGaD
Finasteride—CYP3A5—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000372	0.0048	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000371	0.00479	CbGpPWpGaD
Finasteride—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000366	0.00473	CbGpPWpGaD
Finasteride—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000362	0.00221	CcSEcCtD
Finasteride—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000354	0.00216	CcSEcCtD
Finasteride—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000352	0.00454	CbGpPWpGaD
Finasteride—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000333	0.0043	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000332	0.00428	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000332	0.00428	CbGpPWpGaD
Finasteride—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000328	0.002	CcSEcCtD
Finasteride—Progesterone—CYP1A1—chronic obstructive pulmonary disease	0.000322	0.291	CrCbGaD
Finasteride—Infection—Prednisone—chronic obstructive pulmonary disease	0.000322	0.00196	CcSEcCtD
Finasteride—Progesterone—CYP1A2—chronic obstructive pulmonary disease	0.00031	0.281	CrCbGaD
Finasteride—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000307	0.00396	CbGpPWpGaD
Finasteride—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000306	0.00395	CbGpPWpGaD
Finasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000305	0.00394	CbGpPWpGaD
Finasteride—Testosterone—CYP1A1—chronic obstructive pulmonary disease	0.000304	0.275	CrCbGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000296	0.00382	CbGpPWpGaD
Finasteride—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000295	0.0038	CbGpPWpGaD
Finasteride—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000295	0.0018	CcSEcCtD
Finasteride—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000281	0.00171	CcSEcCtD
Finasteride—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000281	0.00171	CcSEcCtD
Finasteride—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000279	0.0017	CcSEcCtD
Finasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000276	0.00356	CbGpPWpGaD
Finasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000274	0.00353	CbGpPWpGaD
Finasteride—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00027	0.00348	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00027	0.00348	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000267	0.00344	CbGpPWpGaD
Finasteride—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000257	0.00157	CcSEcCtD
Finasteride—SRD5A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000245	0.00316	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000245	0.00316	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000242	0.00312	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000242	0.00312	CbGpPWpGaD
Finasteride—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000239	0.00145	CcSEcCtD
Finasteride—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00142	CcSEcCtD
Finasteride—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000229	0.0014	CcSEcCtD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000226	0.00291	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000226	0.00291	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000224	0.0029	CbGpPWpGaD
Finasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000222	0.00286	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000221	0.00286	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000221	0.00285	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000221	0.00285	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000218	0.00282	CbGpPWpGaD
Finasteride—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000217	0.00279	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000216	0.00278	CbGpPWpGaD
Finasteride—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000214	0.00131	CcSEcCtD
Finasteride—Rash—Prednisone—chronic obstructive pulmonary disease	0.000204	0.00124	CcSEcCtD
Finasteride—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000204	0.00124	CcSEcCtD
Finasteride—SRD5A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000203	0.00263	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000203	0.00263	CbGpPWpGaD
Finasteride—Headache—Prednisone—chronic obstructive pulmonary disease	0.000203	0.00124	CcSEcCtD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000201	0.0026	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000197	0.00254	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000195	0.00252	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000193	0.00249	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000187	0.00241	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000185	0.00238	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000181	0.00234	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000179	0.00231	CbGpPWpGaD
Finasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000175	0.00226	CbGpPWpGaD
Finasteride—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000173	0.00223	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000172	0.00222	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.00017	0.00219	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.00017	0.00219	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.00017	0.00219	CbGpPWpGaD
Finasteride—Testosterone—ALB—chronic obstructive pulmonary disease	0.000169	0.153	CrCbGaD
Finasteride—SRD5A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000167	0.00216	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000167	0.00216	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000163	0.0021	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000162	0.00209	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000161	0.00207	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00016	0.00206	CbGpPWpGaD
Finasteride—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000157	0.00203	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000156	0.00201	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000156	0.00201	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000151	0.00195	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000149	0.00192	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000148	0.00191	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000148	0.00191	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000142	0.00183	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000139	0.00179	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000135	0.00175	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000133	0.00172	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000132	0.0017	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000131	0.00169	CbGpPWpGaD
Finasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.00164	CbGpPWpGaD
Finasteride—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.00162	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000124	0.0016	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000123	0.00158	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000118	0.00152	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000116	0.0015	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.00133	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—ALB—chronic obstructive pulmonary disease	0.000101	0.0013	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—ALB—chronic obstructive pulmonary disease	0.000101	0.0013	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—NOS3—chronic obstructive pulmonary disease	9.61e-05	0.00124	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.61e-05	0.00124	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	9.48e-05	0.00122	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.07e-05	0.00117	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.97e-05	0.00116	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—ALB—chronic obstructive pulmonary disease	8.96e-05	0.00116	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.69e-05	0.00112	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.57e-05	0.00111	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	8.45e-05	0.00109	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.86e-05	0.00101	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.54e-05	0.000973	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.44e-05	0.00096	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.29e-05	0.000812	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.28e-05	0.00081	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.2e-05	0.0008	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	6.11e-05	0.000788	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.78e-05	0.000746	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.7e-05	0.000736	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.68e-05	0.000733	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.48e-05	0.000707	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.4e-05	0.000697	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.62e-05	0.000596	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	4.56e-05	0.000589	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.41e-05	0.000569	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	4.17e-05	0.000537	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.84e-05	0.000495	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.34e-05	0.000431	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	3.3e-05	0.000426	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.2e-05	0.000413	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.16e-05	0.000407	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	3.01e-05	0.000388	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.94e-05	0.000379	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.92e-05	0.000377	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.84e-05	0.000367	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.79e-05	0.00036	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.77e-05	0.000358	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.64e-05	0.000341	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.31e-05	0.000299	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.28e-05	0.000294	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.13e-05	0.000274	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.02e-05	0.00026	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	1.9e-05	0.000245	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.81e-05	0.000234	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.55e-05	0.0002	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.53e-05	0.000198	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.4e-05	0.000181	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	1.37e-05	0.000177	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.31e-05	0.000169	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.29e-05	0.000166	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.08e-05	0.000139	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.06e-05	0.000137	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.88e-06	0.000128	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.37e-06	0.000121	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	6.37e-06	8.22e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	6.09e-06	7.86e-05	CbGpPWpGaD
